Objective: To determine the effect of drastic weight loss on arterial compliance, inflammatory and metabolic parameters in patients with morbid obesity with and without cardiovascular risk factors who underwent laparoscopic adjustable gastric banding (LAGB). Design: Open prospective study, morbidly obese subjects divided into low-and high-risk group were evaluated before and 4 months after LAGB. Subjects: Forty-one Caucasian subjects aged between 16 and 55 years, with morbid (grade 3) obesity (20 low-risk and 21 highrisk subjects) who underwent LAGB and completed a 16-week follow-up. Measurments: Patients were evaluated at baseline and 4 months after LAGB for body mass index (BMI), arterial blood pressure (BP), metabolic factors including lipid profile, HbA1C, insulin, C-peptide, fibrinogen, hs-C reactive protein (CRP) and Homeostasis model assessment-insulin resistance (HOMA-IR). Arterial elasticity of large and small arteries was evaluated using pulse-wave contour analysis method (HDI CR 2000, Eagan, Minnesota) at baseline and after 4 months. Results: Body mass index reduction induced by LABG, from 43.5575.11 to 35.1074.87 in low-risk patients and from 42.9073.22 to 35.0073.24 in high-risk patients, significantly improved small artery elasticity (SAE) from 6.3072.74 to 7.2571.85, in morbidly obese patients with multiple cardiovascular risk factors (high-risk group). Improvement in SAE was accompanied by improvement of arterial BP, glucose and lipid metabolism, and reduction of CRP values. Conclusion: Although dramatic weight reduction induced by surgical intervention was associated with similar changes in body weight and significant improvement of metabolic and inflammatory parameters in two groups of obese patients, SAE improved only in high-risk patients.
Introduction
Obesity is an increasing public health problem in developed countries and has been shown to induce multiple metabolic abnormalities, such as hypertension, dyslipidemia and insulin resistance. [1] [2] [3] Obesity may also be associated with early vascular changes. Excess body fat, abdominal visceral fat and larger waist circumference have been identified as risk factors for accelerated arterial stiffening in young and older adults. [4] [5] [6] During the recent years, technological progress has enabled reliable measurement of vascular compliance, a means of assessing the early stages of vascular disease. One such technique, arterial pulse-wave contour analysis, involves quantifying the amount of arterial stiffening and can be regarded as a valid marker of generalized atherosclerosis 7, 8 , as well as a predictor of cardiovascular mortality. [9] [10] [11] Estimation of vascular compliance may serve as a surrogate end point for morbid risk and treatment benefit. 12 Treatment of obesity is beneficial. Weight loss significantly improves cardiovascular risk factors profile in obese subjects; however, long-term maintenance of reduced body weight can be described as unsuccessful. Conventional weight management, such as dietary approach, is unsatisfactory because obesity relapses. Interventions to improve long-term weight maintenance are therefore needed in order to treat obesity effectively, especially in morbidly obese patients; in these, surgical intervention is also considered. Laparoscopic adjustable gastric banding (LAGB) is a minimally invasive surgical procedure that yields a drastic reduction of gastric volume by placing a silicone band around the gastric body. Laparoscopic adjustable gastric banding has been proven effective in inducing a significant and persistent weight loss, reduction of arterial blood pressure (BP), and improved glucose and lipid metabolism. 13, 14 The procedure is performed under general anesthesia and is completely reversible. Laparoscopic adjustable gastric banding is now regularly applied in a few European centers and has recently been approved by the Food and Drug Administration in the United States. However, the progressive rise in the prevalence of obesity will inevitably mean that only a small proportion of obese patients will actually be treated by surgery. What is required is a better way of identifying patients who may particularly benefit from surgical intervention. The present study was designed to determine the effect of LAGB-associated drastic weight loss on arterial compliance, inflammatory and metabolic parameters in patients with morbid obesity with and without cardiovascular risk factors.
Materials and methods

Subjects
The study group consisted of 44 Caucasian subjects (32 female subjects) aged between 16 and 55 years, with morbid (grade 3) obesity according to World Health Organization criteria. 2, 3 According to the protocol, approved by the local ethics committee, the following criteria qualify patients for LAGB eligibility: age,16-66 years; body mass index (BMI) greater than 40.0 kg/m 2 , or greater than 35.0 kg/m 2 in the presence of comorbidities. Patients with obesity secondary to endocrinopathies (Cushing's syndrome, hypothyroidism) were excluded as were patients with hemodynamic instability, gastrointestinal inflammatory diseases, risk of upper gastrointestinal bleeding, alcohol and drug addiction and psychiatric disorders. Study participants were classified as hypertensive if systolic blood pressure (SBP) was X140 mm Hg, diastolic blood pressure (DBP) X90 mm Hg or if they were taking antihypertensive medication. Subjects with fasting blood glucose levels of more than 126 mg/dl on at least two blood samples, or who were taking antidiabetic medications, were defined as diabetic. Patients were classified as hyperlipidemic if total cholesterol 4220 mg/dl, low-density lipoprotein (LDL) 4160, or triglyceride levels 4200, or if the patients were taking lipid-lowering agents. Low high-density lipoprotein (HDL) cholesterol was defined as HDL o40 mg/dl. Subjects were classified as current smokers if they smoked at least 10 cigarettes per day. According to the above-mentioned cardiovascular risk factors (CVRF), patients were divided into two groups: low risk and high risk. The low-risk group included obese patients with one CVRF or less, whereas high risk had two or more CVRF.
At the beginning of the study, all patients underwent screening procedures including comprehensive psychological and psychiatric evaluation, blood chemistry, complete blood count, urine analysis and electrocardiogram. After LAGB, subjects were reevaluated by the physician and a dietitian monthly during a 16-week follow-up period. For the first month after LAGB, the patients received 850 kcal/day semiliquid diet, composed of 30% protein, 20% fat and 60% carbohydrate. One month after LAGB, a solid diet, consisting of 1000-1050 kcal/day, was reintroduced.
Outcome measures
Chemistry. The patients were evaluated at baseline for BMI and arterial BP.
Blood was drawn for complete chemistry and metabolic factors, including lipid profile, HbA1C, insulin, C-peptide, fibrinogen and hs-C reactive protein (CRP). Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated by the following formula: fasting plasma insulin (mU/ml) Â fasting plasma glucose (mg/dl)/405. 15 Identical evaluation was performed at 2 and 4 months after surgical intervention. Arterial compliance was determined at the baseline visit and every month during the 4-month follow-up.
Arterial compliance measurements. Evaluations were performed between 0800 and 1100 am, in a quiet, temperature-controlled laboratory. Radial arterial waveforms were recorded for 30 s, with the subject in a supine position. The pressure transducer amplifier system was connected to a specially designed device (Model CR-2000, Hypertension Diagnostics Inc., Eagen, MN, USA). The passive transient response of the arterial vasculature to the initial loading conditions was determined by analyzing the diastolic portion of the pressure pulse-wave form. This technique, which has been recently validated 16 and used extensively, [17] [18] [19] was performed with a simple noninvasive radial pulse-wave recording and a computer analysis of the diastolic decay, providing separate assessment of the large artery or capacitive compliance (C1) and small artery reflective or Informed consent. The study was approved by the local Institutional Review Board and the patients signed a full informed consent.
Statistical analysis
Statistical analyses were performed on SPSS 9.0 (SPSS Inc., Chicago, IL, USA). Distributions of continuous variables were assessed for normalcy using the Kolmogorov-Smirnov test (cutoff Po0.01). Descriptive statistics for continuous variables are reported as mean7standard deviation. Arterial compliance and metabolic parameters were compared between low-and high-risk patient groups using the t-test for independent samples. Within each patient group, differences from baseline to the 16-week follow-up were compared using the t-test for paired samples. Changes from baseline variables were calculated by subtracting baseline from follow-up values. Associations between changes from baseline values were described using Pearson's correlation coefficients. All tests are two-sided and considered significant at Po0.05.
Results
Of the 44 obese patients who underwent LAGB, 41 completed the 16-week follow-up; 20 low-risk and 21 highrisk subjects (three patients did not return for the 16-week assessment).
Baseline characteristics
As shown in Table 1 , age, gender distribution and BMI were not different between low-and high-risk patients. The low-risk group, comprised of individuals with one or fewer CVRFs, included 20 obese patients. Of the 20 participants, seven had no CVRF whereas 13 had one CVRF. The most commonly observed CVRFs were low HDL (21.7%), hypertension (17.4%) and hyperlipidemia (13.0%).
The high-risk group, comprised of individuals with two or more CVRFs, included 21 obese patients. In this group, nine patients had two CVRFs, whereas 12 patients had three or more CVRFs. In this group, the most commonly observed CVRFs were hypertension (66.7%), hyperlipidemia (66.7%), low HDL (57.1) and diabetes (19.0%).
At baseline, SBP and DBP were significantly lower in the low-risk group compared to the high risk group (131720 vs 144717 mm Hg, Po0.03 and 69712 vs 78712 mm Hg, Po0.01). Small artery elasticity (SAE) index was significantly higher in low-risk compared to high-risk patients (9.0375.11 vs 6.3072.74 ml/mm Hg*100, Po0.04). Large artery elasticity (LAE) index tended to be higher in low-risk patients; however, this difference did not reach statistical significance (16.3176.27 vs 13.5574.71 ml/mm Hg*100, Po0.11).
Changes in arterial stiffness, clinical and metabolic parameters post-LAGB in low-risk patients Table 2 shows BMI, hemodynamic and arterial compliance parameters in the group of low-risk patients followed up for 16 weeks. BMI declined from 43.5575.11 to 35.1074.87 kg/m 2 (Po0.0001). SBP and DBP did not change during follow-up. At baseline, pulse rate was 76710 bpm, and decreased significantly to 6976 bpm at the 16-week followup point (Po0.0001). Neither LAE, nor SAE index improved from baseline to 16 week post-LAGB in the low-risk group. Change from baseline LAE was associated with change from baseline SBP (r ¼ À0.48, P ¼ 0.03), but not with DBP. Conversely, change from baseline SAE was associated with DBP (r ¼ À0.46, P ¼ 0.04), but not with SBP.
Metabolic parameters pre-and 16 week post-LAGB are displayed in Table 3 . As can be seen, significant improvements in total cholesterol (P ¼ 0.02) and CRP (Po0.03) were observed during 16 week of follow-up. Although fasting plasma glucose levels did not change during the study, other parameters of glucose metabolism improved significantly compared to baseline: fasting insulin decreased from 36.85 to 20.54 mU/ml (P ¼ 0.001), HbA1C decreased from 6.06 to 5.63% (Po0.0001), C-peptide declined from 3.671.0 to 2.970.67 pg/ml (Po0.0001) and HOMA-IR improved from 8.73 to 4.70 (P ¼ 0.001). Change from baseline LAE and change from baseline SAE were both significantly associated with change from baseline SBP (r ¼ À0.63, P ¼ 0.002 and r ¼ À0.59, P ¼ 0.005, respectively). Change from baseline LAE was significantly associated with change from baseline DBP (r ¼ À0.57, P ¼ 0.007); however, the association between DBP and SAE was marginal (r ¼ À0.4, P ¼ 0.06).
As shown in Table 3 , significant improvements in metabolic parameters were observed in total cholesterol, from a value of 226.3741.7 mg/dl at baseline to 195.1722.5 mg/dl 16-weeks post-LAGB (Po0.0001). This decline was not accompanied by significant changes from baseline in HDL or LDL. Serum triglycerides declined from 289.4755.5 mg/dl at baseline to 169.9741.1 at follow-up (Po0.04). Compared to baseline, post-LAGB CRP levels had also declined significantly (1.370.7 vs 0.970.4 U, P ¼ 0.001).
Although fasting plasma glucose decreased marginally from 125.10774.69 to 97.71717.50 (P ¼ 0.056), all other post-intervention glucose metabolism parameters improved significantly compared to baseline values: insulin level decreased from 39.25726.17 to 21.2177.78 mU/ml (P ¼ 0.002), HbA1C decreased from 6.9972.56 to 5.6970.58% (P ¼ 0.011), C-peptide decreased from 4.571.8 to 3.170.1 pg/ml, Po0.001, and HOMA-IR improved from 11.8079.41 to 5.2172.41 pg/ml (P ¼ 0.0001o).
Changes from baseline values for selected hemodynamic and metabolic parameters by group are shown in Table 4 . As Effect of a rapid weight loss M Shargorodsky et al can be seen, although weight loss was marginally greater in the low-risk group (24.376.1 vs 21.273.6 kg, P ¼ 0.056), significantly greater reductions in SBP, DBP and serum triglycerides were observed among high-risk patients. Additionally, the greater reductions from baseline in HbA1c and serum cholesterol were marginally significant. Correlations of the total cohort demonstrate a significant association between delta SAE and delta SVR (Po0.001), whereas delta SVR significantly correlates with delta total cholesterol, delta fasting blood glucose, delta SBP and delta DBP. Association between change from baseline SAE and delta weight was not detected.
Discussion
The prominent finding of the present study is that dramatic weight reduction induced by LABG significantly improved SAE in morbidly obese patients with multiple cardiovascular risk factors (high-risk group). Improvement in SAE was accompanied by improvement of arterial BP, and glucose and lipid metabolism, and reduction of CRP values. These findings comply with the concept that significant weight reduction induces a decrease of several risk factors for cardiovascular disease (CVD). Improvement of these factors can not only halt the progression but also improve decreased vascular elasticity, which has been accepted as a surrogate marker of vascular disease.
The association between arterial stiffening and aging has been described in many populations. 16 Numerous cardiovascular risk factors, including diabetes, hypertension, hyperlipidemia, cigarette smoking and increasing adiposity, are also associated with increased arterial stiffness, often referred as 'premature arterial stiffening'. [20] [21] [22] The effect of adiposity on arterial stiffness may begin during childhood and affect the vascular system at a very early stage of vascular aging. 23 Several pre-existing risk factors, including diabetes, hypertension and dyslipidemia, may particularly increase the negative cardiovascular effects of elevated adiposity, causing greater CVD risk at an earlier age in adulthood.
There are a number of mechanisms by which increasing adiposity and obesity might contribute to arterial stiffening, both in short and in long term. First, the state of insulin resistance that commonly accompanies obesity impairs endothelium-dependent vasodilatation 24 and increases the local activity of a variety of growth factors in vascular tissue, 25, 26 promoting collagen production and the development of vascular smooth muscle cell (VSMC) hypertrophy. 27 In addition, the pro-inflammatory state typical of obesity may promote free radical formation, leading to the development of oxidative stress. Elevated sympathetic nerve activity and norepinephrine-evoked vascular smooth muscle cell contraction may also contribute to obesity-related arterial stiffness. Finally, obesity might increase arterial stiffness through the hormone leptin, which has been shown to promote VSMC proliferation and angiogenesis. 28, 29 Obesity is often accompanied by the metabolic syndrome, and substantial improvement of the latter also occurs with weight loss. Interestingly, clinical evidence that improvement of metabolic parameters in obesity reduces vascular stiffening is lacking. The importance of the present study consists of the evidence that dramatic weight reduction in obese patients with multiple CVRF corrects metabolic derangements and improves small vessel elasticity. This improvement is not present in obese patients without CVRF. Our results comply with another publication in which in uncomplicated obesity, reduction of body weight also significantly decreased BP without a concomitant improvement in isobaric compliance of the carotid artery. 30 Weight loss in obese individuals leads to rapid improvement in cardiovascular risk factors; however, data regarding long-term effect of weight loss on mortality are inconsistent. A recent study suggested that deliberate weight loss in overweight subjects without known co-morbidities may be hazardous in the long term. 31 These data do not contradict the beneficial effect of weight loss in obese individuals who have already developed co-morbidities; however, more research will be needed to evaluate influence of intentional weight loss in the large population of otherwise healthy obese individuals. A significant change in LAE among high-risk patients during 16 weeks of follow-up was not observed; this complies also with other publication in which reduced SAE but not LAE was found to be independent risk marker for cardiovascular events. 32 Endothelial dysfunction and alterations in function and structure of the arterial wall, representing atherosclerotic changes, are detectable earlier in small arterioles and microvasculature than in large conduit arteries. Small artery elasticity should be an earlier marker for disease because it is uniquely sensitive to nitric oxide. Effect of a rapid weight loss M Shargorodsky et al Thus, assessment of small artery function and structure is essential. 34 The correlation between delta SAE and delta SVR found in our study is logical as SVR represents degree of constriction of the small resistance vessels, which should be associated with SAE changes. Lack of change in LAE may imply that the process of 'tissue repair' in the large arteries is lengthy and may take more than 16 weeks of stable weight reduction.
Because the main effect of weight reduction is metabolic, the mechanism of the impressive improvement in hemodynamic parameters and in SAE is probably induced by metabolic changes, associated with a decrease in the degree of hyperinsulinemia and insulin resistance and improvement in lipid metabolism. Both SBP and DBP decreased significantly during the study; moreover, significant associations were detected between change from baseline BP and arterial elasticity parameters. This implies that the effect of reduced BP on improved arterial elasticity cannot be excluded. Changes from baseline SBP and DBP were significantly greater in the high-risk group. Reduction from baseline serum triglycerides was signficantly greater, whereas reduction from baseline HbA1C and cholesterol was marginally greater in high-risk patients (Table 4) , despite a marginally greater reduction from baseline weight in the low-risk patients. These findings may suggest a role for metabolic parameters in the improved SAE measures observed in the high-risk group.
Despite a marginally significantly greater reduction from baseline weight in low-risk compared to high-risk patients, a significant improvement in SAE was not observed. It is important to note that most of the obese patients in this group were normotensive, with normal metabolic and inflammatory parameters at baseline, and that significant post-LAGB changes in BP were not observed during followup. In low-risk patients, LAE and SAE were also within normal range before surgical intervention and did not change during follow-up. Thus, this group of patients, despite being obese, had different, healthier metabolic milieu, which improved significantly during the study but to a lesser degree than those in the high-risk patients. Therefore, although all obese patients attained significantly lower BMI and exhibited improvement in metabolic parameters, patients with higher CVRF load also exhibed improvement in vascular elasticity.
There are several limitations in the present study. Although low-and high-risk groups were well-matched in terms of gender distribution, age and BMI, having a pure control group with no risk factors would have been preferable to the low-risk group. Unfortunately, the number of obese subjects with no risk factors would not be enough to have them separately. And by the current definition, two groups of equal size could be formed. In addition, several studies demonstrated that BMI decreased substantially and reached the plateau at approximately 12 months after gastric restrictive surgery. However, the most impressive decrease in BMI was observed after 3 months of surgery. 13, 14 In our study, at 4 months after surgery, the subjects' weight may not have reached a steady state and their metabolism might not reflect their weight stabilization.
Conclusions
The present study shows that patients with morbid obesity and higher cardiovascular risk factor load have decreased arterial compliance of small arteries compared to obese patients with low cardiovascular risk. Although dramatic weight reduction induced by surgical intervention was associated with similar changes in body weight and significant improvement of metabolic and inflammatory parameters in these two groups of obese patients, SAE improved only in high-risk patients. Thus, it appears that obese patients with a higher risk factor load may enjoy an additional benefit from dramatic weight reduction induced by surgical intervention -specifically, improved arterial elasticity.
